Physician profile
Wesley Aaron Nesbit
NPI 1407465040
$2,318.65
in general payments reported to CMS, 2019-2025
14 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $867 · 2023: $580 · 2024: $552 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800 · Travel and Lodging: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.69 |
| Travel and Lodging | $652.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,126.90 | 2022-2023 | Prostep |
| Seapearl East, INC | $392.06 | 2024 | |
| Kerecis Limited | $224.09 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Nalu Medical, INC. | $148.41 | 2025 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $146.11 | 2024-2025 | Qutenza |
| Integra Lifesciences Corporation | $79.92 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Collegium Pharmaceutical, INC. | $50.09 | 2024-2025 | Belbuca |
| Treace Medical Concepts, INC. | $39.96 | 2024-2025 | |
| Depuy Synthes Sales INC. | $25.71 | 2024 | Dynacord |
| Globus Medical, INC. | $23.60 | 2025 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.16 | 2024 | Jublia |
| Ibsa Pharma INC. | $16.88 | 2024 | Licart, Tirosint |
| Paratek Pharmaceuticals, INC. | $15.33 | 2023 | Nuzyra |
| Orthofix Medical, INC. | $12.43 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Nesbit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.